Effect of quinacrine, a phospholipase a2 inhibitor on stress and chemically induced gastroduodenal ulcers

Digestion

Volumn 58, Issue 2, 1997, Pages 129-137

  Al Moutaery, Ahmed R ^a   Tariq, M ^b  

^a IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

^b The General Directorate of Armed Forces Health Services   (Saudi Arabia)

Author keywords

Duodenal ulcers; Gastric ulcers; Nonprotein sulfhydryls; Phospholipase A2 inhibitor; Quinacrine

Indexed keywords

ALCOHOL; INDOMETACIN; MEPACRINE; MERCAPTAMINE; PHOSPHOLIPASE A2 INHIBITOR;

ACID SECRETION; ANIMAL EXPERIMENT; ARTICLE; FEMALE; GASTRODUODENAL ULCER; IMMOBILIZATION STRESS; MALE; NONHUMAN; PRIORITY JOURNAL; STOMACH MUCUS; STOMACH SECRETION; STOMACH WALL; STRESS ULCER; WATER IMMERSION;

ANIMALS; CYCLOOXYGENASE INHIBITORS; CYSTEAMINE; DUODENAL ULCER; ENZYME INHIBITORS; ETHANOL; FEMALE; GASTRIC ACID; GASTRIC JUICE; GASTRIC MUCOSA; IMMERSION; INDOMETHACIN; MALE; PEPTIC ULCER; PHOSPHOLIPASES A; PYLORUS; QUINACRINE; RADIATION-PROTECTIVE AGENTS; RATS; STOMACH ULCER; STRESS; SULFHYDRYL COMPOUNDS;

EID: 0030947073     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000201435     Document Type: Article

References (91)

1. Hills BA, Butler BD, Liehtenbcrger LM: Gastric mucosal barrier: Hydrophobic lining to the lumen of the stomach. Am J Physiol 1983:244: 561-568.
2. Kiviluote T, Paimela H, Mustonen H, Kivilaakso E: Exogenous surface-active phospholipid protects necturus gastric mucosa against luminal acid and barrier-breaking agents. Gastroenterology 1991:100:38-46.
3. Davenport HW: Gastric mucosal injury by fatty acid and acetyl salicylic acids. Gastroenterology 1964:46:245-253.
4. Lichtenberger LM, Graziani LA, Dial EJ, Butler BD, Hills BA: Role of surface active phospholipids in gastric cytoprotcction. Science 1983;219:1327-1328.
5. Szelenvi I, Engler H: Cytoprotective role of gastric surfactant in the ethanol-produced mucosal injury of the rat. Pharmacology 1986:33: 199-205
6. Swarm RA, Ashley SW, Soybcl DI, Ordway FS, Cheung LY: Protective effect of exogenous phospholipid on aspirin-induced gastric mucosal injury. Am J Surg 1987;153:48-53.
7. Sakata T, Nakamura E, Tsuruta Y, Tamaki M, Teraoka H, Tojo H, et al.: Presence of pan-creatic-type phospholipase A: mRNA in rat gastric mucosa and lung. Biochim Biophys Acta 1989;1007:124-126.
8. Dimbcrg J, Gustafson-Svard C, Westrom B, Tagcsson C, Soderkvist P: Group I phospholi-pasc A: mRNA in rat glandular stomach and pancreas. Ontogcnic development and effects of cortisone acetate. Biochim Biophys Acta 1992;1130:47-51.
9. Mansbach GM: Phospholipases: Old enzymes with new meaning. Gastroenterology 1990:98: 1369-1382.
10. Sun XM, Hscuh W: Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor. J Clin Invest 1988; 81:1328-1331.
11. Krenitsky TA, Tuttle JV, Cattau EL, Wang P: A comparison of the distribution and electron acceptor specialities of xanthine oxidase and aldehyde oxidase. Comp Biochcm Physiol [B] 1974:49:687-703.
12. Parks DA, Bulkey DB, Granger DN: Role of oxygen derived free radicals in digestive tract diseases. Surgery 1983:94:415-422.
13. Rainsford KD: Microvaseular injury during gastric mucosal damage by anti-inflammatory drugs in pigs and rats. Agents Actions 1983; 13: 5-6.
14. Schoenberg M, Muhl E, Sellin D, Younes M, Schildberg F, Hagluno V: Posthypotensive generation of superoxide free radicals - possible role in the pathogenesis of the intestinal mucosal damage. Act Clin Scand 1984:150:301 -309.
15. Boros M, Karacsony G, Kaszaki J, Nagy S: Rcperfusion mucosal damage alter complete intestinal ischemia in the dog: The effects of antioxidanl and phospholipase Ay inhibitor therapy. Surgery 1993:113:183-191.
16. Tariq M, Aqecl AM: Gastric ulcer and cytopro-lective effects of dipyridamole in rats. J Pharmacol ExpTher 1990;253:946-949.
17. Otamiri T, Tagcsson C: Role of phospholipase Ai and oxygenated free radicals in mucosal damage after small intestinal ischemia and reperfusion. Am J Surg 1989:157:562-565.
18. Parks DA, Williams TK, Beckman JS: Conversion of xanthine dehydrogenase to oxidase in ischemic rat intestine: A réévaluation. Am J Physiol 1988;245:G768-G774.
19. Granger DN: Role of xanthine oxidase and granulocytes in ischemia reperfusion injury. Am J Physiol 1988,240: H1269-H1275.
20. Rollo IM, Drugs used in chemotherapy of malaria; in Goodman LS. Gilman A (eds): The Pharmacological Basis of Therapeutics. New York. MacMillan, 1980, pp 1038-1078.
21. Chiaricllo M, Ambrosio G, Cappelli-Bigazzi M, Perone-Filardi P, Tritto I, Nevola E, Golina P: Reduction in infarct size by the phospholipase inhibitor quinacrine in dogs with coronary artery occlusion. Am Heart J 1990; 120:801-807.
22. Shcn C, Wang D, Chang M, Hsu K: Protective effect of mcpacrine on hypoxia-reoxvgenation induced acute lung injury in rats. J Appl Physiol 1995:78:225-231.
23. Struhar D, Kivitz S, Topilsky M: Quinacrine inhibits oxygen radicals relase from human alveolar macrophages. Int J Immunopharma-col 1992;14:275-277.
24. Das DK, Barna PK, Jones RM: Release of fatty acid-binding protein from ischemic-rcpcrfuscd rat heart and its prevention by mcpacrine. Biochim Biophys Acta 1991:1073:394-401.
25. Sargent CA, Vesterguist O, McCullough JR, Ogletree ML, Grover GJ: Effect of phospholipase A2 inhibitors quinacrine and 7.7-dimcth-yleicosadienoic acid in isolated globally ischemic rat hearts. J Pharmacol Exp Ther 1992: 262:1161-1167.
26. Shayevitz JR, MeShane AJ, Traystman RJ, Gurtner GH: Mcpacrine attenuates pulmonary' vasoreactivity in rabbits. J Appl Physiol 1989: 66:1921-1926.
27. Valcavi U, Caponi R, Brambilla A, Palmira F, Minoja F, Bernin F, Mustani R, Fumagall R: Gastric antisecretory, antiulcer and cytoprotective properties of 9-hydroxy-19,20-bis-nor-prostanoid acid in experimental animals. Arz-neimittclforschung 1982:32:657-663.
28. Schiantarelli P, Cadel S, Folco GC: Gastropro-tectivc effects of morniflumatc. an csterified antiinflammatory drug. Arzneimittelforschung 1984;34:885-890.
29. Shay FI, Komarov SA, Fels SE, Meraze D, Grucnstein M, Siplet H: A simple method for the uniform production of gastric ulceration in the rat. Gastroenterology 1945:5:43-61.
30. Takagi K, Okabo S, Saziki R: A new method of experimental chronic ulcers in rats. Jpn J Pharmacol 1969:19:418-426.
31. Bhargava KP, Gupta MB, Tangri KK: Mechanism of ulcerogenic activity of indomcthacin and ocyphcnbutazone. Eur J Pharmacol 1973: 22:191-195.
32. Szabo S: Animal model of human disease. Cys-teantinc indueed acute and chronic duodenal ulcer in the rat. Am J Pathol 1978:93:273-276.
33. Robert A, Nejamis IE, Lancaster C, Davis JP, Field SO, Hanchar AJ: Mild irritants prevent gastric necrosis through adaptive eytoprotcc-tion mediated by prostaglandin. Am J Physiol 1983:245:0113-43121.
34. Corne SJ, Morrisev SM, Woods RJ: A method for the quantitative estimation of gastric barrier mucus. J Physiol (Lond) 1974:242:112-117.
35. Scdlak J, Lindsay RH: Estimation of total protein bound and nonprotein sulfhydrvl groups in tissue with Ellman's reagent. Anal Biochem 1968:25:192-195.
36. Goa KL, Monk JP: Enprotil: A preliminary review of its pharmacodynamics and pharmacokinetic properties and therapeutic efficacy in the treatment of peptic ulcer diseases. Drugs 1987:3:539-559.
37. Hanson PJ, Halt JF: Intracellular signalling and regulation of gastric acid secretion. Q J Exp Physiol 1989:7:607-634.
38. Shamburek RD, Schubert ML: Pharmacology of gastric acid inhibition. Baillieres Clin Gastroenterol 1993;7:23-54.
39. + and Cl/HCOl exchange by stimulation of acid secretion in the parietal cell. J Biol Chem 1988;263:14703-14711.
40. 2+ exchange by quinacrine. Am J Physiol 1987:252:24-29.
41. +-ATPase activity by phospholipase A; and several lysophospholi-pids: Possible role of phospholipase A; in noradrenaline release from cerebral cortical svnap-tosomcs. J Pharm Pharmacol 1989:41:450-458.
42. Evans RJ, Surprenant A: Effect of phospholi-pasc A; inhibitors on coupling of alpha 2-adrenoceptors to inwardly rectifying potassium currents in guinea-pig submucosal neurons. Br J Pharmacol 1993:110:591-596.
43. Seiler SM, Cragoe EJ, Jones LR: Demonstration of a Na’/H* exchange activity in purified canine sacrolcmmal vesicles. J Biol Chem 1985;260:4869-4876.
44. 2+ ions in gastric acid secretion by the rat isolated stomach. Agents Actions 1986:18:201-204.
45. Fiddiar-Green RG, Pittcnger G, Kothanv P, Vinik AI: Role of calcium in stimulating-secrel-ing coupling of antral gastrin release. Endocrinology 1983:112:753-760.
46. Ohncda A, Kobavashi T, Niher J: Effect of Ca antagonists, nifedipine and verapamil on endocrine function. Tohoka J Exp Med 1983:140: 153-159.
47. Kirkegaard P. Poulsen SS. Loud FB. Halse C. Christiansen J: Cysteamine induced duodenal ulcer and gastric secretion in the rat. Scand J Gastroenterol 1980;15:621-624.
48. 2+ channel. J Biol Chem 1991: 266:10787-10795.
49. Stokkc M, Hagelin EM, Poulsson C, Patel R, Haile Y, Brors O: Inhibition by amiloride and quinacrine of specific ['Hjnitrcndipinc binding to rat cardiac membranes. J Pharmacol Exp Ther 1992:260:1366-1372.
50. Fabia R, Rajab A, Willen R, Andersson R, Bengmark S: Effect of putative phospholipase A; inhibitors on acetic acid-induced acute colitis in the rat. Br J Surg 1993:80:1199-1204.
51. Gutli PH. Kozbur X: Pathogenesis of gastric microcirculator and mast cell changes in restraint stress. Am J Dig Dis 1968:13:530-535.
52. Mancinelli S, De la Fuente G. Manriquez V, Aracena M. Munoz R. Mancinelli S. Munoz S: The etiopathogenesis of the acute stress ulcer. The role of oxygen free radicals Rev Med Chile 1990:118:965-970.
53. Brodie DA, Marshall RW, Moreno OM: Effect of restraint on gastric acidity in the rat. Am J Physiol 1962:202:812-814.
54. Kitigawa H, Fujiwara M, Osumi Y: Effects of water immersion stress on gastric secretion and mucosal blood flow in rats. Gastroenterology 1979:77:298-302.
55. Watanabe K: Some pharmacological factors involved in formation and prevention of stress ulcers in rats. Chem Pharm Bull 1966:14:101-107.
56. Otamiri T, Lindahl M, Tagcsson C: Phospholipase A inhibition prevents mucosal damage associated with small intestinal ischemia in rats. Gut 1988:29:489-494.
57. Yoshikawa T, Miyagawa H, Yoshida N, Sugino S, Kondo M: Free radical lipid peroxidation in stress-induced gastric mucosal lesions in rats: in Sevanian A (ed): Lipid Peroxidation in Biological System. Champaign. American Oil Chemist's Society. 1988. pp 213-224.
58. Boros M, Karacsony G, Kaszaki J, Nagy S: Repcrlusion mucosal damage after complete intestinal ischemia in the dog: The effects of antioxidant and phospholipase A; inhibition therapy. Surgery 1991; 113:184-191.
59. Nishida T, Miwa H, Shigcmatsu A, Yamamoto M, Iida M, Fujishama M: Increased arachi-donic acid composition of phospholipids in colonic mucosa from patients with active ulcerative colitis. Gut 1987:28:1002-1007.
60. Wallace JL, McKnight GW, Keenan CM, Boyles NIA, MacNanghton WK: Effect of leu-kotrieneson susceptibility of the rat stomach to damage and investigation of the mechanism of action. Gastroenterology 1990:98:1178-1186.
61. Kapui Z, Boer K, Rozsa I, Blasko G, Hermecz I: Investigations of indomethacin-induced ulcer in rats. Arzncimittelforschung 1993.43: 767-771.
62. Jolly SR, Lucchcsi BR: Effect of BW755c in an occl jsion-repcrfusion model of ischemic myocardial injury. Am Heart J 1983:106:8-13.
63. Bednar M, Smith B, Pinto A, Mullanc KM: Nafazotrom-induced salvage of ischemic myocardium in anesthetized dogs is mediated through inhibition of neutrophil function. Circ Res 1985;57:131-141.
64. Moncada S, Salmon JA, Vane JR, Whittle BJR: Formation of prostacyclin (PGL) and its products, 6-oxo-PGF by the gastric mucosa of several species. J Physiol (Lond) 1978:275:4.
65. Armstrong SC, Ganóte CE: Effects of the phos-pholipasc inhibitor mepacrinc on injury in ischemia and metabolically inhibited adult isolated myocytes. Am J Pathol 1991; 138:545-555.
66. Griffin M, Rav W, Schaffner W: Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. Ann Intent Med 1988:109:359-363.
67. Hawkey CJ: Non-steroidal ant I-inflammatory drugs and peptic ulcers. BMJ 1990:300:278-284.
68. Yoshikawa T, Naito Y, Kishi A, Tomii T, Kaneko T, Iinuma S, Ichikawa H, Yasuda M, Takahashi S, Kondo M: Role of active oxygen, lipid peroxidation and antioxidants in the pathogenesis of gastric mucosal injury induced by indomelhacin in rats. Gut 1993:34:732-737.
69. Wallace JL: Non-steroid anti-inflammatory drug gastropathy and cytoprotcction: Pathogenesis and mechanisms re-examined. Scand J Gastroenterol Suppl 1992; 192:3-8.
70. Konturek SJ, Brzozowski T, Drozdowiez D, Beck G: Role of Icukotricncs in acute gastric lesions induced by ethanol, taurocholate. platelet-activating factor and stress in rats. Dig Dis Sci 1988:33:806-813.
71. Peskar BM, Hoppe U, Lange K, Peskar BA: Effect of nonsteroidal anti-inflammatory drugs on rat gastric mucosal lcukotriene Ca and prostanoid release: Relation to ethanol-induced injury. BrJ Pharmacol 1988;93:937-943.
72. Arndt H, Russell JB, Kurosc I, Kubes P, Granger DN: Mediatorsofleukocyte adhesion in rat mesenteric venules elicited by inhibition of nitric oxide synthesis. Gastroenterology 1993: 105:675-680.
73. Dennis EA, Hazlett TL, Deems RA, Ross ML, Ulevitch RJ: Phospholipase in the macrophage; in Baily JM (ed): Prostaglandins, Leuko-tricnes and Lipoxines: Biochemistry. Mechanism of Action, and Clinical Applications. New York, Plenum Press. 1985, pp 213-220.
74. Dennis EA, Rhec SG, Billah MM, et al: Role of phospholipases in generating lipid second messengers in signal transduction. FASEB J 1991; 5:2068-2077.
75. Tramposch KM, Chilton FH, Stanley PL, Franson RC, Havens MB, Neltleton DO, Dav-eru LB. Darling IM, Bonnev RJ: Inhibition of phospholipase A; blocks cicosanoid and platelet activating factor biosynthesis and has topical anti-inflammatory activity. J Pharmacol Exp Ther 1994;271:852-859.
76. Chiariello M, Ambrosio G, Cappelli-Bigazzi M, Perrone-Filardi P, Sifola L, Brigante F: A biochemical method for the quantitation of myocardial scarring after coronary artery occlusion. J Mol Cell Cardiol 1986:18:283-290.
77. Tauber AI, Simons ER: Dissociation of human neutrophil membrane depolarization, respiratory burst stimulation and phospholipid metabolism by quinacrinc. FEBS Lett 1983:156: 161-164.
78. Szabo S, Reynolds ES, Lichtenberger LM, Haith LR, Dzau VJ: Pathogensis of duodenal ulcer. Gastric hyperacidity caused by propio-nilrilc and cysteamine in rats. Res Commun Chem Pathol Pharmacol 1977:16:311-323.
79. Otamiri T, Sjodahl R, Tagesson C: Lysophos-phatidvleholine potentiates the increase in mucosal permeability after small intestinal ischemia. Scand J Gastroenterol 1986:21:1131 -1136.
80. Bell AE, Sellers LA, Allen A, Cunliffe WJ, Morris ER, Ross-Murphy SB: Properties of gastric and duodenal mucus: Effects of proteolysis, disulfide reduction, bile, acid, ethanol and hypertonicity on mucus gel structure. Gastroenterology 1985:88:269-280.
81. Slomiany BL, Piasek A, Sarosiek J, Slomiany A: The role of surface and intracellular mucus in gastric mucosal protection against hydrogen ion. Compositional differences. Scand J Gastroenterol 1985:20:1191-1196.
82. Allen A, Sellers LA, Bennett MK: The gastric mucosal epithelial barrier: Role of mucus and fibrin. Scand J Gastroenterol 1987;22:6-13.
83. Allen A, Hutton DA, Leonard AJ. Pearsson JP, Seller LA: The role of mucus in the protection of the gastroduodenal mucosa. Scand J Gastroenterol 1986;21:71-77.
84. Wallace JL, Whittle BJR: Role of mucus in the repair of gastric epithelial damage in the rat. Gastroenterology 1986:91:603-611.
85. Szabo S, Trier JS, Frankel PW: Sulfhvdryl compounds may mediate gastric cytoprotection. Science 1981:214:200-202.
86. Miller TA, Li D, Kuo YJ, Schmidt KL, Shan-bour LL: Nonprotcin sulfhvdryl compounds in canine gastric mucosa: Effect of PGE and ethanol. Am J Physiol 1985:249:137-144.
87. Hiraishi H, Terano A, Ota S, Mutoh H, Sugimoto T, Harada T, Razandi M, Ivey KJ: Protection of cultured rat gastric cells against oxidant induced damage by exogenous glutathione. Gastroenterology 1994:106:1199-120.
88. Guardia T, Guzman JA, Pestchanker MJ, Guerreiro E, Giordano OS: Mucus synthesis and sulfhvdryl groups in cytoprotection mediated by dehydroleucodinc. a sesquiterpene lactone. J Nat Prod 1994;57:507-509.
89. Salim AS: Sulhvdryl-containing agents: A new approach to the problem of refractory peptic ulceration. Pharmacology 1992:45:301-306.
90. Kosower NS, Kosower EM: The glutathione status of cells. Int RevCvtol 1978;58:109-160.
91. Allen A: Structure of gastrointestinal mucus glycoproteins and the viscous and gel-forming properties of mucus. Ur Med Bull 1978:34:28-33.